US · Healthcare · Health Information Services
EPS came in at -0.85 against a street estimate of -1.19 — a beat of 28.6%.
Analysts rate DarioHealth Corp a strong buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $13.60.
| Fund | Stake |
|---|---|
| Nantahala Capital Management, LLC | 12.47% |
| Vanguard Capital Management, LLC | 0.67% |
| Geode Capital Management, LLC | 0.59% |
| BlackRock Inc | 0.39% |
| Vanguard Fiduciary Trust Co | 0.38% |
| Citadel Advisors Llc | 0.25% |
| Northern Trust Corp | 0.14% |
| Vanguard Global Advisers, LLC | 0.03% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for DarioHealth Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.